info@allievapharma.com


  • 24/7
    Customer Service
  • ISO 9001
    Certification Company
  • WHO-GMP
    Certified Company
OUR CATALOGUE OUR CATALOGUE

    • Product Details

    Bortezomib Injection IP 3.5mg

    Bortezomib Injection IP 3.5mg


    Brand NameBORTELIEVA 3.5MG
    CompositionBortezomib Injection IP 3.5mg
    Manufacture ByAllieva Pharma Private Limited
    FormInjection
    PackingVial
    Country Of OriginIndia

    ENQUIRY! Enquire via WhatsApp

    Description

    Description

    BORTLIEVA contains Bortezomib, a proteasome inhibitor used in cancer treatment. It works by blocking proteasomes in cells, leading to accumulation of proteins and apoptosis (cell death) of cancer cells.

    Uses

    Bortezomib is used in adults for:

    1. Multiple myeloma
         – Newly diagnosed or relapsed/refractory

    2. Mantle cell lymphoma
         – Previously treated patients

    3. Sometimes in combination with other chemotherapies for certain hematologic cancers.

    Side Effects

    Common side effects:

    •  Fatigue, weakness

    •  Peripheral neuropathy (tingling/numbness)

    •  Nausea, vomiting

    •  Diarrhea or constipation

    •  Low blood counts (thrombocytopenia, neutropenia)

    Serious side effects:

    •  Severe infections

    •  Severe neuropathy

    •  Heart problems (rare)

    •  Liver function abnormalities

    Monitor blood counts and liver function regularly.

    Dosage

    •  1.3 mg/m² IV or SC on Days 1, 4, 8, 11 of a 21-day cycle (common regimen)

    •  Dose may be adjusted based on side effects or prior therapies

    •  Can be given intravenously (IV) or subcutaneously (SC)

    NOTE: This medicine should be taken only under a doctor’s supervision.

    24/7 Clients Support

    Best Price

    Quality Assurance
    function changeImage(elem, src) { document.getElementById("mainImage").src = src; document.querySelectorAll(".thumbnail-container img").forEach(img => img.style.border = "2px solid transparent"); elem.style.border = "2px solid #007bff"; }